Good Day BIO Newsletter

A new poll finds most Americans want the Biden administration to protect IP rights on the international stage, and both consumers and investors are increasingly interested in products made from captured carbon. (560 words, 2 minutes, 48 seconds)

With a new bipartisan proposal to restore the full R&D tax deduction on the table, now’s the time for you to take action—we tell you how. Plus, five takeaways from BIO’s participation in JPM Week. (599 words, 2 minutes, 59 seconds)

ICYMI: R&D tax deductions are now amortized over five years—but you can take action to help restore R&D tax exemptions and support innovation. New York recently became the first state to regulate the treatment of seeds with neonicotinoids—here’s why it matters. (526 words, 2 minutes, 37 seconds)

A recent analysis in Health Affairs explains why we need to restore orphan drug incentives, and a new report highlights the toll of the record number of climate-related disasters in the U.S. (433 words, 2 minutes, 9 seconds) We’re off on Monday in recognition of Martin Luther King Jr. Day. We’ll resume publication on Tuesday, January 16.

New research highlights how gene editing can accelerate viable crops to feed the world, and CARB-X announces funding for AMR R&D. (399 words, 2 minutes)

We're in the midst of the second-highest COVID surge in the U.S.—but vaccines work, if people get them. New climate data released yesterday highlights the importance of advancing biotech solutions. (440 words, 2 minutes, 12 seconds)

A small fix to the Inflation Reduction Act could boost rare disease R&D—and voters support it. Plus, researchers say they found the gene that allows wheat to grow in extreme temperatures. (487 words, 2 minutes, 26 seconds)

JPM Week begins, Congress is back to work, and the likelihood of the next pandemic looms. (501 words, 2 minutes, 30 seconds)

Writing in The Hill, BIO’s Chief Policy Officer John Murphy explains how IP enables innovation and access to COVID technology. Meanwhile, BIO has joined an amicus brief against a lawsuit that questions a drug company’s decisions about the pace of drug development. (481 words, 2 minutes, 24 seconds)

BIO helps report on biotech’s contributions to global sustainability. One such contribution is the effort to battle a surge in dengue. (496 words, 2 minutes, 28 seconds)